What clinical evidence for an LH ceiling?

By Filicori Marco   Cognigni Graciela E.   Ciampaglia Walter  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1556-1557

Oxford University Press

Access to resources Recommend Favorite

Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation

By Loumaye Ernest  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 314-322

Oxford University Press

Access to resources Recommend Favorite

What is the LH ceiling level for follicular growth arrest in late follicular phase?

By Ho Jason Yen‐Ping  

Human Reproduction, Vol. 19, Iss. 2, 2004-02 ,pp. : 463-464

Oxford University Press

Access to resources Recommend Favorite

Evidence that oxytocin is a physiological component of LH regulation in non‐pregnant women

By Evans J.J.   Reid R.A.   Wakeman S.A.   Croft L.B.   Benny P.S.  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1428-1431

Oxford University Press

Access to resources Recommend Favorite

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy

By Huirne Judith A.F.   van Loenen Andre C.D.   Schats Roel   McDonnell Joseph   Hompes Peter G.A.   Schoemaker Joop   Homburg Roy   Lambalk Cornelis B.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 359-367

Oxford University Press

Access to resources Recommend Favorite